FOXP3 and COVID-19: Also, they found that CD4+/CD8+ ratio, B cells, FoxP3+ Tregs, and FoxP3 median fluorescence did not show any significant difference between early and late responders of hospitalized COVID-19 patients (Table 1) [50].